Cargando…

Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8(+) T cells and exhibit a distinct CD95(hi) B cell phenotype

AIMS/HYPOTHESIS: The aim of this study was to characterise islet autoantibody profiles and immune cell phenotypes in slow progressors to type 1 diabetes. METHODS: Immunological variables were compared across peripheral blood samples obtained from slow progressors to type 1 diabetes, individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanna, Stephanie J., Powell, Wendy E., Long, Anna E., Robinson, Emma J. S., Davies, Joanne, Megson, Clare, Howell, Alexandra, Jones, Taz J., Ladell, Kristin, Price, David A., Dayan, Colin M., Williams, Alistair J. K., Gillespie, Kathleen M., Wong, F. Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228996/ https://www.ncbi.nlm.nih.gov/pubmed/32157332 http://dx.doi.org/10.1007/s00125-020-05114-7

Ejemplares similares

Islet Autoantibody Testing: An End to the Trials and Tribulations?
por: Bingley, Polly J., et al.
Publicado: (2013)

Anti-Islet Autoantibodies Trigger Autoimmune Diabetes in the Presence of an Increased Frequency of Islet-Reactive CD4 T Cells
por: Silva, Diego G., et al.
Publicado: (2011)

Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes
por: Boldison, Joanne, et al.
Publicado: (2021)

Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study
por: Long, Anna E., et al.
Publicado: (2018)

Electrochemiluminescence Assays for Human Islet Autoantibodies
por: Gu, Yong, et al.
Publicado: (2018)

Birth and coming of age of islet autoantibodies
por: Bonifacio, E., et al.
Publicado: (2019)

The Core Cysteines, (C909) of Islet Antigen-2 and (C945) of Islet Antigen-2β, Are Crucial to Autoantibody Binding in Type 1 Diabetes
por: Elvers, Karen T., et al.
Publicado: (2013)

CD4(hi)CD8(low) Double-Positive T Cells Are Associated with Graft Rejection in a Nonhuman Primate Model of Islet Transplantation
por: Choi, Yun Jung, et al.
Publicado: (2018)

Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
por: Marzinotto, Ilaria, et al.
Publicado: (2023)

Islet autoantibody profiles associated with higher diabetes risk in Lithuanian compared with English schoolchildren
por: Long, A. E., et al.
Publicado: (2020)

Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay
por: Gu, Yong, et al.
Publicado: (2017)

Prevalence of Islet Autoantibodies in Type 1 Diabetes
por: Dayal, Devi, et al.
Publicado: (2017)

Anti-Islet Autoantibodies in Type 1 Diabetes
por: Kawasaki, Eiji
Publicado: (2023)

Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus
por: Anteby, Roi, et al.
Publicado: (2021)

Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort
por: Bravis, Vassiliki, et al.
Publicado: (2018)

Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda
por: Kibirige, Davis, et al.
Publicado: (2022)

CD103 Expression Is Required for Destruction of Pancreatic Islet Allografts by CD8(+) T Cells
por: Feng, Ye, et al.
Publicado: (2002)

Increased CD34 in pancreatic islet negatively predict islet β-cell decrease in type1 diabetes model
por: Huang, Shichen, et al.
Publicado: (2022)

Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors
por: Diamantopoulos, Stavros, et al.
Publicado: (2008)

My Child Is Islet Autoantibody Positive: Impact on Parental Anxiety
por: Johnson, Suzanne Bennett, et al.
Publicado: (2017)

Australia and New Zealand Islet and Pancreas Transplant Registry Annual Report 2018—Islet Donations, Islet Isolations, and Islet Transplants
por: Webster, Angela C., et al.
Publicado: (2019)

Australia and New Zealand Islet and Pancreas Transplant Registry Annual Report 2019: Islet Donations, Islet Isolations, and Islet Transplants
por: Webster, Angela C., et al.
Publicado: (2020)

IsletLab: an application to reconstruct and analyze islet architectures
por: Félix-Martínez, Gerardo J.
Publicado: (2021)

High TLR7 Expression Drives the Expansion of CD19(+)CD24(hi)CD38(hi) Transitional B Cells and Autoantibody Production in SLE Patients
por: Wang, Ting, et al.
Publicado: (2019)

The role of CD95 and CD95 ligand in cancer
por: Peter, M E, et al.
Publicado: (2015)

Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children
por: Lamichhane, Santosh, et al.
Publicado: (2023)

Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers
por: Webb‐Robertson, Bobbie‐Jo M., et al.
Publicado: (2020)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Elevations in blood glucose before and after the appearance of islet autoantibodies in children
por: Warncke, Katharina, et al.
Publicado: (2022)

Impact of GAD65 and IA2 autoantibodies on islet allograft survival
por: Lemos, Joana R. N., et al.
Publicado: (2023)

Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics
por: Grace, Sian Louise, et al.
Publicado: (2022)

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood
por: Vehik, Kendra, et al.
Publicado: (2011)

What Have Slow Progressors Taught Us About T1D—Mind the Gap!
por: Gillespie, Kathleen M., et al.
Publicado: (2019)

Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis
por: Siraj, Elias S., et al.
Publicado: (2018)

Islet Amyloid Polypeptide Is a Target Antigen for Diabetogenic CD4(+) T Cells
por: Delong, Thomas, et al.
Publicado: (2011)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
por: Piemonti, Lorenzo, et al.
Publicado: (2013)

Autoantibodies against islet cell antigens in children with type 1 diabetes mellitus
por: Cheng, Bi-Wen, et al.
Publicado: (2018)

Autoimmune thyroid disease correlates to islet autoimmunity on zinc transporter 8 autoantibody
por: Cai, Yun, et al.
Publicado: (2021)

Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
por: Ng, Kenney, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fg3jou47m0bol8ph9v6ih86q5a